Cover Image

Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies

Inhibition of Carbonic Anhydrases (CAs) has been clinically exploited for many decades for a variety of therapeutic applications. Within a research project aimed at developing novel classes of CA inhibitors (CAIs) with a proper selectivity for certain isoforms, a series of derivatives featuring the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ciro Milite (Author), Giorgio Amendola (Author), Alessio Nocentini (Author), Silvia Bua (Author), Alessandra Cipriano (Author), Elisabetta Barresi (Author), Alessandra Feoli (Author), Ettore Novellino (Author), Federico Da Settimo (Author), Claudiu T. Supuran (Author), Sabrina Castellano (Author), Sandro Cosconati (Author), Sabrina Taliani (Author)
Format:	Book
Published:	Taylor & Francis Group, 2019-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies
by: Emma Baglini, et al.
Published: (2021)

Carbonic anhydrase activation profile of indole-based derivatives
by: Elisabetta Barresi, et al.
Published: (2021)

Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms
by: Melissa D'Ascenzio, et al.
Published: (2017)

Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors
by: Suleyman Akocak, et al.
Published: (2018)

Activation of human α-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine schiff bases and bis-spinaceamine substituted derivatives
by: Suleyman Akocak, et al.
Published: (2019)

Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails
by: Fadi M. Awadallah, et al.
Published: (2018)

Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors
by: P. V. Sri Ramya, et al.
Published: (2017)

Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors
by: Simone Giovannuzzi, et al.
Published: (2023)

The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2020)

Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives
by: Gustavo Provensi, et al.
Published: (2021)

Antihistamines, phenothiazine-based antipsychotics, and tricyclic antidepressants potently activate pharmacologically relevant human carbonic anhydrase isoforms II and VII
by: Francesco Fiorentino, et al.
Published: (2023)

Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi
by: Alane Beatriz Vermelho, et al.
Published: (2018)

Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action
by: Marco Bragagni, et al.
Published: (2017)

Aryl derivatives of 3H-1,2-benzoxaphosphepine 2-oxides as inhibitors of cancer-related carbonic anhydrase isoforms IX and XII
by: Anastasija Balašova, et al.
Published: (2023)

7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2020)

New sulfonamides containing organometallic-acylhydrazones: synthesis, characterisation and biological evaluation as inhibitors of human carbonic anhydrases
by: Yosselin Huentupil, et al.
Published: (2019)

Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and Mycobacterium tuberculosis β-class enzyme Rv3273
by: Tanvi V. Wani, et al.
Published: (2018)

Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
by: Andrea Angeli, et al.
Published: (2022)

Derivatives of 4-methyl-1,2,3-benzoxathiazine 2,2-dioxide as selective inhibitors of human carbonic anhydrases IX and XII over the cytosolic isoforms I and II
by: Jekaterīna Ivanova, et al.
Published: (2023)

Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties
by: Daniela De Vita, et al.
Published: (2017)

Vanillin enones as selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII. The out of the active site pocket for the design of selective inhibitors?
by: Leonardo E. Riafrecha, et al.
Published: (2021)

Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line
by: Ismail Koyuncu, et al.
Published: (2019)

Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamides as carbonic anhydrase isoforms I and II inhibitors
by: Mohammad M. Al-Sanea, et al.
Published: (2019)

Novel 2-indolinones containing a sulfonamide moiety as selective inhibitors of candida β-carbonic anhydrase enzyme
by: Atilla Akdemir, et al.
Published: (2019)

Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida®) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms
by: Claudiu T. Supuran, et al.
Published: (2021)

Sulfonamide inhibition studies of two β-carbonic anhydrases from the ascomycete fungus Sordaria macrospora, CAS1 and CAS2
by: Daniela Vullo, et al.
Published: (2018)

Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase
by: Mikhail Krasavin, et al.
Published: (2020)

Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms
by: Wagdy M. Eldehna, et al.
Published: (2022)

An overview on the recently discovered iota-carbonic anhydrases
by: Alessio Nocentini, et al.
Published: (2021)

Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII
by: Tarfah Al-Warhi, et al.
Published: (2022)

Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII
by: Sara Seršen, et al.
Published: (2019)

Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors
by: Nora Astrain-Redin, et al.
Published: (2023)

Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides
by: Morteza Abdoli, et al.
Published: (2017)

Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII
by: Andrea Angeli, et al.
Published: (2017)

Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors
by: Alessandra Rogato, et al.
Published: (2019)

Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases
by: Mikhail Krasavin, et al.
Published: (2017)

Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A2B AR Physio-Pathological Implications
by: Elisabetta Barresi, et al.
Published: (2021)

Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii
by: Sonia Del Prete, et al.
Published: (2020)

Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance
by: Stepan K. Krymov, et al.
Published: (2022)

Carbonic Anhydrase Inhibitors as Novel Antibacterials in the Era of Antibiotic Resistance: Where Are We Now?
by: Alessio Nocentini, et al.
Published: (2023)